Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
NESS ZIONA, Israel, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments…
59,500€
-0,42%
Echtzeit-Aktienkurs Sol-Gel Technologies Ltd.
Bid:
Ask:
Nachrichten zur Sol-Gel Technologies Ltd. Aktie
Sol-Gel Technologies: SGT-610 birgt Milliardenpotenzial bei Gorlin-Syndrom – Mizuho rät zum Kauf
Mizuho startet Coverage: Die Investmentbank hat Sol-Gel Technologies mit einem "Outperform"-Rating und einem Kursziel von 285 US-Dollar in die…
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of -374.36% and -89.29%, respectively, for the quarter ended December 2025. Do…
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of 92.31% and 99.29%, respectively, for the quarter ended September 2024. Do…